J. Anderson

1 ATOMIC: 97% RVR FOR PSI-7977 + PEG/RBV × 12 WEEK REGIMEN IN HCV GT1: AN END TO RESPONSE-GUIDED THERAPY?

D. Bernstein, T. Hassanein, D. Nelson, 2012 .

Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-negative chronic Hepatitis B: Week 72 TDF data and week 24 Adefovir dipivoxil switch data (Study 102)

M. Manns, T. Berg, P. Marcellin, 2008 .

57 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 102)

P. Marcellin, A. Horban, H. Senturk, 2008 .

TWO YEAR TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT AND ADEFOVIR DIPIVOXIL (ADV) SWITCH DATA IN HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102), PRELIMINARY ANALYSIS

M. Buti, P. Marcellin, G. Dusheiko, 2008 .

Posttreatment exacerbation of hepatitis B virus (HBV) infection in long-term HBV trials of emtricitabine.

F. Rousseau, H. Momméja-Marin, E. Mondou, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The antiviral response to Tenofovir disoproxil fumarate (TDF) is comparable in Lamivudine (LAM)-naïve and LAM-experienced subjects treated for chronic Hepatitis B (CHB)

M. Manns, T. Berg, S. Mauss, 2008 .

74 THE ANTIVIRAL RESPONSE TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IS COMPARABLE IN LAMIVUDINE (LAM)-NAIVE AND LAM-EXPERIENCED SUBJECTS TREATED FOR CHRONIC HEPATITIS B (CHB)

M. Manns, T. Berg, M. Rizzetto, 2008 .

75 TENOFOVIR DISOPROXIL FUMARATE (TDF) IS HIGHLY ACTIVE FOR TREATMENT OF CHRONIC HEPATITIS B IN SUBJECTS WITH CIRRHOSIS

M. Buti, M. Sherman, S. Strasser, 2008 .

Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotide

M. Farthing, J. Wass, G. Besser, 1995, Clinical endocrinology.

HBsAg kinetics of decay and baseline characteristics of HBeAg-positive patients with chronic hepatitis B following 3 years of tenofovir disoproxil fumarate (TDF) treatment

P. Marcellin, S. Zeuzem, E. Gane, 2010 .

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update

T E Klein, L Gong, M Pirmohamed, 2017, Clinical pharmacology and therapeutics.